From the looks of this article Invitrohair could be in US human clinical trials in 2019. At least that’s what it sounds like to me. What does everyone else think? The most important statements in the article below are:
“Invitrohair tells me they’re invited by the US FDA for a pre-IND-Meeting, prior to the start of a clinical trial for the use of engineered hypoimmunogenic and autologous hair follicles, hypoimmunogenic dermal papilla cells and hypoimmunogenic melanocytes in the US within the next 6 months.”
https://www.folliclethought.com/invitrohair-announces-new-hair-follicle-patent/#comment-25404
So I assume these are HF cells and follicles that can be transplanted from one person to another?
I don’t know for sure but it looks to me like the follicle cells are NOT autologous or else Invitrohair wouldn’t have made them hypoimmunogenic. So I think the answer to your question is affirmative.
And if they’re not autologous that’s good because if they use donor cells they would surely be younger and healthier than ours so it wouldn’t matter if our own donor area hairs are starting to thin. It sounds to me like it means that even a NW7 could recover a full head of healthy terminal hairs with this procedure.
And it also looks like they’re ready for human clinical trials by the end of the year.
1 Like
Well, it looks like generating hypoimmunogenic induced pluripotent stem cells has already been done… so given what others have already achieved by Tsuji and Stemson, it’s not a stretch to see someone making follicles out of these
https://www.pnas.org/content/116/21/10441